Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Emergence of bedaquiline-resistant tuberculosis and of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis strains with rpoB Ile491Phe mutation not detected by Xpert MTB/RIF in Mozambique: a retrospective observational study.
Barilar, I; Fernando, T; Utpatel, C; Abujate, C; Madeira, CM; José, B; Mutaquiha, C; KRANZER, K; Niemann, T; Ismael, N; De Araujo, L; Wirth, T; Niemann, S; Viegas, S;
2023
The Lancet. Infectious diseases, (2023).24 3 10.1016/s1473-3099(23)00498-x.
Ending TB means responding to socially produced vulnerabilities of all genders.
Ringwald, B; Mwiine, AA; Chikovore, J; Makanda, G; Amoah-Larbi, J; Millington, KA; HORTON, KC;
2023
BMJ Global Health, (2023).8 12 10.1136/bmjgh-2023-014151.
Estimated reductions in TB prevalence following population-wide screening.
RICHARDS, A; HORTON, K; MCCREESH, N; HOUBEN, R;
2023
(2023).
Acceptability of using the medication monitor and experience of a differentiated care approach for TB treatment adherence among people living with TB in South Africa.
Mukora, R; Ahumah, B; Maraba, N; Orrell, C; Jennings, L; Naidoo, P; FIELDING, KL; Velen, K; Charalambous, S; Chetty-Makkan, CM;
2023
PLOS global public health, (2023).3 10 10.1371/journal.pgph.0001885.
Assessing the efficacy of tuberculosis regimens in the presence of treatment non-adherence.
DODD, M; Fielding, K; CARPENTER, J; THOMPSON, J; ELBOURNE, D;
2023
(2023).
Diagnostics for childhood tuberculosis: a marathon rather than a sprint.
TOGUN, TO; KAMPMANN, B;
2023
The Lancet. Infectious diseases, (2023).24 2 10.1016/s1473-3099(23)00517-0.
Transmission pathways across the spectrum of TB disease – how much transmission are we missing?.
McCaffrey, T; RICHARDS, A; Emery, J; HOUBEN, R; HORTON, K;
2023
(2023).
Immunological factors linked to geographical variation in vaccine responses.
Van Dorst, MM A R; Pyuza, JJ; NKURUNUNGI, G; Kullaya, VI; Smits, HH; Hogendoorn, PC W; Wammes, LJ; Everts, B; ELLIOTT, AM; Jochems, SP; Yazdanbakhsh, M;
2023
Nature reviews. Immunology, (2023).24 4 10.1038/s41577-023-00941-2.
Four-Month High-Dose Rifampicin Regimens for Pulmonary Tuberculosis.
Jindani, A; Atwine, D; GRINT, D; Bah, B; Adams, J; Ticona, ER; Shrestha, B; Agizew, T; Hamid, S; Jamil, B; Byamukama, A; Kananura, K; Mugisha Taremwa, I; Bonnet, M; Camara, LM; Bah-Sow, OY; Bah, KS; Bah, NM; Sow, M; Ticona Huaroto, CE; Mugruza Pineda, R; Tandukar, B; Raya, BB; Shrestha, N; Mathoma, A; ... Harrison, TS.
2023
NEJM evidence, (2023).2 9 10.1056/EVIDoa2300054.
Recent Travel and Tuberculosis in Migrants: Data From a Low-Incidence Country.
SCHWALB, A; Kayumba, K; HOUBEN, RM G J; Bothamley, GH;
2023
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (2023).78 3 10.1093/cid/ciad672.